Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

MEDIQON Group AG (MDCKF) Stock Price & Analysis

MDCKF Stock Chart & Stats

$51.11-$2.89(-5.35%)
At close: 4:00 PM EDT
$45$50$553 Aug17 Aug31 Aug11 Sep28 Sep12 Oct26 Oct
Day’s Range
$49.25 - $52.97
52-Week Range
$30.18 - $56.38
Previous Close
$54.00
Volume
N/A
Average Volume (3M)
5,433
Market Cap
$1.30B
Enterprise Value
$1.19B
Total Cash (Recent Filing)
$115.41M
Total Debt (Recent Filing)
$265.58M
Price to Earnings (P/E)
―
Beta
0.09
Next Earnings
May 27, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Revenue growth has remained exceptionally strong and accelerated again in 2025, indicating expanding commercial activity and market reach. If the company can convert this scale into healthier economics, the enlarged revenue base could support stronger operating leverage and durable growth.

Positive Cash Generation

Positive operating cash flow throughout 2021–2025 and consistently positive free cash flow provide an important funding base for ongoing operations. This internally generated liquidity offers some resilience while the company works through substantial accounting losses and increased leverage.

Substantial Equity Base

The sizeable equity base and asset base provide a balance-sheet cushion that can help absorb operating volatility. Although leverage has increased materially, this capital foundation gives the company more capacity to manage obligations and pursue its healthcare and life sciences activities.

Bears Say

Severe Profitability Deterioration

The 2025 profitability collapse is a major fundamental weakness because revenue growth is not translating into earnings. Negative gross profit and large EBIT and net losses indicate that the current cost structure or integration and one-off impacts are overwhelming scale benefits.

Sharp Debt Increase

The large year-over-year increase in debt materially changes the company’s financial risk profile, especially alongside deeply negative earnings. Higher leverage can reduce financial flexibility and makes sustained cash generation more important for meeting obligations and funding future activity.

Declining Free Cash Flow

Free cash flow remains positive, but its substantial decline in 2025 weakens the company’s ability to offset losses and support its heavier debt burden. Maintaining cash generation will be increasingly important because accounting losses and leverage leave less room for operational setbacks.

MDCKF FAQ

What was MEDIQON Group AG’s price range in the past 12 months?
MEDIQON Group AG lowest stock price was $30.18 and its highest was $56.38 in the past 12 months.
What is MEDIQON Group AG’s market cap?
MEDIQON Group AG’s market cap is $1.30B.
When is MEDIQON Group AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MEDIQON Group AG’s earnings last quarter?
MEDIQON Group AG released its earnings results on Oct 09, 2026. The company reported -$0.994 earnings per share for the quarter.
Is MEDIQON Group AG overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MEDIQON Group AG pay dividends?
MEDIQON Group AG does not currently pay dividends.
What is MEDIQON Group AG’s EPS estimate?
MEDIQON Group AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MEDIQON Group AG have?
MEDIQON Group AG has 25,364,090 shares outstanding.
What happened to MEDIQON Group AG’s price movement after its last earnings report?
MEDIQON Group AG reported an EPS of -$0.994 in its last earnings report. Following the earnings report the stock price went up 0.319%.
Which hedge fund is a major shareholder of MEDIQON Group AG?
Currently, no hedge funds are holding shares in MDCKF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology